PRESS RELEASES AVECTAS Appoints Daniel Castro as Chief Business Officer January 11, 2021 Avectas Opens Canadian Development Site November 5, 2020 Avectas to Present at Cell and Gene Meeting on the Mesa Conference October 12, 2020 Avectas featured in TTP Healthcare Blog – ‘Special Delivery: can advanced…’ July 15, 2020 Avectas to Present at the OCTS Conference July 7, 2020 Avectas and UC Davis Collaborate on Cell Engineering Technology June 8, 2020 Avectas recognised in the Tracxn ‘Soonicorn Club 2020: Top Tech Startups In Ireland’ May 15, 2020 Avectas and ONK Therapeutics to develop off-the shelf cancer therapy May 6, 2020 Avectas Completes Significant Series C Funding Bringing Total Invested Equity to Over $40 Million April 16, 2020 Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office April 8, 2020 Avectas featured in Genetic Engineering and Biotech News – ‘Cell and Gene Therapy Sector Needs to Automate’ April 8, 2020 Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies March 24, 2020 Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies March 3, 2020 Avectas featured in 2020 Year Book of Irish Pharma Chem February 5, 2020 Avectas joins the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy January 16, 2020 Avectas to Participate in PHACILITATE Webinar November 26, 2019 Avectas recognised as ‘15 Most Promising Biotech Startup’ November 14, 2019 Avectas Raises $10 Million in Equity Finance April 9, 2019 Avectas named ‘Bio Science Lab of the Year’ at The Irish Laboratory Awards 2019 March 7, 2019 Avectas shortlisted in the ‘US- Ireland Research Innovation Awards’ March 7, 2019 Maynooth team secures €2.1m EU funding for cancer therapy March 20, 2018
Avectas Completes Significant Series C Funding Bringing Total Invested Equity to Over $40 Million April 16, 2020
Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office April 8, 2020
Avectas featured in Genetic Engineering and Biotech News – ‘Cell and Gene Therapy Sector Needs to Automate’ April 8, 2020
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies March 24, 2020
Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies March 3, 2020
Avectas joins the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy January 16, 2020